 Recombinant human acetylcholine receptor alpha-subunit induces chronic experimental autoimmune myasthenia gravis synthetic gene N-terminal residues alpha-subunit nicotinic acetylcholine receptor AChR human skeletal muscle inducible expression plasmid fusion protein high yield Escherichia coli native human AChR recombinant human alpha protein AChR-binding AChR-modulating AChR-blocking autoantibodies rats emulsion CFA Bordetella pertussis vaccine supplementary adjuvant minimum dose recombinant protein biochemical signs experimental autoimmune myasthenia gravis EAMG incidence micrograms micrograms serum levels autoantibodies persistent apparent EAMG month Clinical electrophysiological biochemical indices EAMG doses micrograms uniformly severe persistent fatality control extract coli plasmid alpha codon insert adjuvants autoantibodies signs EAMG reproducible new model EAMG recombinant human autoantigen valuable Ag-specific immunotherapeutic strategies applicable myasthenia gravis humans